Glutathione IV Infusion

A 600 mg intravenous glutathione infusion delivered under physician supervision at the Infuzní centrum of Centrum jednodenní chirurgie Pardubice. Glutathione is the body's most abundant endogenous antioxidant — a tripeptide present in virtually every cell, where it neutralises reactive oxygen species, regenerates oxidised vitamins C and E, and drives the liver's phase II detoxification pathways. Oral glutathione supplementation is poorly absorbed (the peptide bond is cleaved in the gut before reaching systemic circulation); IV delivery achieves direct systemic bioavailability. The clinic's infusion centre uses a pharmaceutical 600 mg glutathione preparation in saline solution, administered in 20–30 minutes with nursing supervision. Relevant for detoxification support, antioxidant protection, liver health, and management of chronic oxidative stress.

Glutathione IV infusion at Centrum jednodenní chirurgie Pardubice delivers 600 mg of reduced glutathione (gamma-L-glutamyl-L-cysteinyl-glycine) directly into the bloodstream via a pharmaceutical-grade preparation in saline carrier. The choice of IV over oral administration is clinically significant: the peptide bond in glutathione is efficiently cleaved by intestinal and hepatic peptidases before the molecule reaches systemic circulation in its intact form. Intravenous delivery bypasses this degradation pathway entirely, achieving true systemic delivery of the intact antioxidant molecule. Glutathione's physiological roles are broad and fundamental. As the master endogenous antioxidant, it directly scavenges superoxide radicals, hydrogen peroxide, hydroxyl radicals, and lipid peroxides — the primary reactive oxygen species generated by inflammation, environmental toxins, heavy exercise, chronic stress, and the natural metabolic processes of aerobic respiration. It simultaneously maintains the redox state of other antioxidants: reduced glutathione regenerates ascorbyl radical back to vitamin C and tocopheroxyl radical back to vitamin E, multiplying the antioxidant capacity of those vitamins. In the liver, glutathione is the critical cofactor for glutathione S-transferase (GST), the enzyme family responsible for phase II detoxification — conjugating reactive electrophiles (metabolic intermediates, drugs, environmental chemicals) for export and elimination. At the clinic, the initial physician consultation reviews the patient's indication and medical background. The 600 mg dose is the standard therapeutic dose used across clinical applications. Infusion runs for approximately 20–30 minutes under continuous nursing supervision at the Poliklinika Trnová infusion ward. Patients tolerate this preparation well at standard doses; adverse effects are rare. Common clinical indications for this protocol include: liver support (including support during drug treatment courses with hepatotoxic potential, post-alcohol recovery, or non-alcoholic fatty liver disease); adjunctive antioxidant support during or after periods of intense chemotherapy or radiation; management of chronic oxidative stress in inflammatory conditions; and skin brightening — IV glutathione is well-known in dermatology for its melanin-modulating properties, as it shifts melanin synthesis toward the lighter pheomelanin pathway. For chronic protocols (such as ongoing liver support or systemic antioxidant maintenance), the clinic recommends 1–2 sessions per week over 4–6 months, with the exact course determined by the physician based on clinical response. Single sessions are appropriate for acute detoxification support or post-event recovery. The infusion ward operates Monday, Wednesday, and Friday mornings (08:00–12:00).